BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 11091852)

  • 1. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
    Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
    Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
    Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue.
    Dirnhofer S; Angeles-Angeles A; Ortiz-Hidalgo C; Reyes E; Gredler E; Krugmann J; Fend F; Quintanilla-Martinez L
    Hum Pathol; 1999 Jul; 30(7):781-7. PubMed ID: 10414496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of HLA-A*02 antigen status in Hodgkin's disease and analysis of an HLA-A*02-restricted epitope of the Epstein-Barr virus LMP-2 protein.
    Bryden H; MacKenzie J; Andrew L; Alexander FE; Angus B; Krajewski AS; Armstrong AA; Gray D; Cartwright RA; Kane E; Wright DH; Taylor P; Jarrett RF
    Int J Cancer; 1997 Aug; 72(4):614-8. PubMed ID: 9259400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
    Chabay P; De Matteo E; Merediz A; Preciado MV
    Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein--Barr virus gene polymorphisms in Chinese Hodgkin's disease cases and healthy donors: identification of three distinct virus variants.
    Zhou XG; Sandvej K; Li PJ; Ji XL; Yan QH; Zhang XP; Da JP; Hamilton-Dutoit SJ
    J Gen Virol; 2001 May; 82(Pt 5):1157-1167. PubMed ID: 11297690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease.
    Dolcetti R; Zancai P; De Re V; Gloghini A; Bigoni B; Pivetta B; De Vita S; Carbone A; Boiocchi M
    Blood; 1997 Mar; 89(5):1723-31. PubMed ID: 9057656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual variant of Epstein-Barr virus in Hodgkin/Reed-Sternberg cells: single-cell PCR study on latent membrane protein-1 gene.
    Kim LH; Peh SC; Poppema S
    Int J Cancer; 2003 Nov; 107(2):250-5. PubMed ID: 12949802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter.
    Sjöblom A; Yang W; Palmqvist L; Jansson A; Rymo L
    J Virol; 1998 Feb; 72(2):1365-76. PubMed ID: 9445037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates.
    Sandvej K; Gratama JW; Munch M; Zhou XG; Bolhuis RL; Andresen BS; Gregersen N; Hamilton-Dutoit S
    Blood; 1997 Jul; 90(1):323-30. PubMed ID: 9207468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells.
    Chang MH; Ng CK; Lin YJ; Liang CL; Chung PJ; ChenML ; Tyan YS; Hsu CY; Shu CH; Chang YS
    DNA Cell Biol; 1997 Jul; 16(7):829-37. PubMed ID: 9260926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Internal deletions of the latent membrane protein oncogenes of Epstein-Barr virus in Hodgkin's disease are almost identical with those of Asiatic nasopharyngeal carcinoma].
    Odermatt BF; Heitz PU; Bachmann E; Brousset P; Sandvej K; Knecht H
    Verh Dtsch Ges Pathol; 1994; 78():324-8. PubMed ID: 7534006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
    Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
    J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of Epstein-Barr virus type A strain with the 30 b.p. deletion of the latent membrane protein-1 gene in a Japanese population.
    Oshima M; Azuma H; Okuno A
    Pediatr Int; 1999 Oct; 41(5):490-5. PubMed ID: 10530059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
    Johannsen E; Koh E; Mosialos G; Tong X; Kieff E; Grossman SR
    J Virol; 1995 Jan; 69(1):253-62. PubMed ID: 7983717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism analysis of Epstein-Barr virus isolates from patients with cutaneous natural killer/T-cell lymphoproliferative disorders: A possible relation to the endemic occurrence of these diseases in Japan.
    Xu ZG; Iwatsuki K; Ohtsuka M; Oyama N; Matsui T; Kaneko F
    J Med Virol; 2000 Oct; 62(2):239-46. PubMed ID: 11002254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transactivation of CCL20 gene by Epstein-Barr virus latent membrane protein 1.
    Okudaira T; Yamamoto K; Kawakami H; Uchihara JN; Tomita M; Masuda M; Matsuda T; Sairenji T; Iha H; Jeang KT; Matsuyama T; Takasu N; Mori N
    Br J Haematol; 2006 Feb; 132(3):293-302. PubMed ID: 16409294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.
    Pallesen G; Hamilton-Dutoit SJ; Rowe M; Young LS
    Lancet; 1991 Feb; 337(8737):320-2. PubMed ID: 1671232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of Epstein-Barr virus and strain type assignment in Argentine childhood Hodgkin's disease.
    Preciado MV; De Matteo E; Diez B; Menárguez J; Grinstein S
    Blood; 1995 Nov; 86(10):3922-9. PubMed ID: 7579362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence variation in the Epstein-Barr virus latent membrane protein 1.
    Miller WE; Edwards RH; Walling DM; Raab-Traub N
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2729-40. PubMed ID: 7931159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.